Scandinavian ChemoTech AB Series B (CMOTEC-B) — Cash Flow Reinvestment Rate
Latest as of December 2020:
1.15x
Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Cash Flow Reinvestment Rate of 1.15x as of December 2020, reinvesting Skr239.00K (capex Skr30.00K plus investments Skr-209.00K) from operating cash flow of Skr207.00K. See CMOTEC-B cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
1.15x
(Capex + Investments) / Operating CF
Total Reinvested
Skr239.00K
Capex + Investments
Operating Cash Flow
Skr207.00K
SEK
Capital Expenditures
Skr30.00K
SEK
Annual Cash Flow Reinvestment Rate for Scandinavian ChemoTech AB Series B (None–None)
Year-by-year capital reinvestment analysis for Scandinavian ChemoTech AB Series B. See CMOTEC-B free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow